Immunotherapy
Activation or suppression of the immune system to treat disease
Ratings
0
Nobody has rated this yet. Be the first!
Influences rating
Influences rating
Subject of
66
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.
Identification of essential genes for cancer immunotherapy.
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.
Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells
Cancer immunotherapy
Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy
Candida albicans Immunotherapy for Verrucae Plantaris